Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Belgium's ElaN Languages Acquires Dutch Language Service Provider AVB Vertalingen slator.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from slator.com Daily Mail and Mail on Sunday newspapers.